AEK-9054896-5/10003/1

Abbvie Corporation — FEI 3010173015

Refusal Details

Date
January 21, 2026
Country
Canada
Product Category
Drugs and Biologics
Product Code
58CCA99 ANTIMIGRAINE, NEC
Charges
118,75